Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
Circulation|September 2, 2020
Ticagrelor or Clopidogrel in Elderly Patients With Myocardial Infarction: When the Choice Makes the DifferencePiera Capranzano, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|April 21, 2021
Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary interventionPiera Capranzano, Dominick J Angiolillo
Current Pharmaceutical Design|March 10, 2016
Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACSPiera Capranzano, Claudia Tamburino, Corrado Tamburino
International Journal of Cardiology|May 21, 2011
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in left main patients with intermediate Global RiskDavide Capodanno, Piera Capranzano, Corrado Tamburino
European Heart Journal|January 19, 2024
Aspirin-free antiplatelet strategies after percutaneous coronary interventionsPiera Capranzano, David Moliterno, Davide Capodanno
Reviews on Recent Clinical Trials|March 5, 2010
Clinical development of selective anticoagulants: a state of the artPiera Capranzano, Davide Capodanno, Corrado Tamburino
International Journal of Cardiology|April 5, 2014
CABG versus PCI in diabetic patients with multivessel disease after risk stratification by the SYNTAX score: a pooled analysis of the SYNTAX and FREEDOM trialsDavide Capodanno, Piera Capranzano, Corrado Tamburino
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Discontinuation of anticoagulation therapy after atrial fibrillation ablation: the ALONE-AF and OCEAN studiesMario Campisi, Florinda Bonanno, Piera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 18, 2025
Should MitraClip also be used in less severe functional mitral regurgitation? The RESHAPE-HF2 studyPiera Capranzano, Bianca Pellizzeri, Luca Lombardo
Interventional Cardiology Clinics|August 26, 2019
Pharmacodynamics During Transition Between Platelet P2Y<sub>12</sub> Inhibiting TherapiesPiera Capranzano, Bruno Francaviglia, Dominick J Angiolillo
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Circulation|September 2, 2020
Ticagrelor or Clopidogrel in Elderly Patients With Myocardial Infarction: When the Choice Makes the DifferencePiera Capranzano, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|April 21, 2021
Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary interventionPiera Capranzano, Dominick J Angiolillo
Current Pharmaceutical Design|March 10, 2016
Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACSPiera Capranzano, Claudia Tamburino, Corrado Tamburino
International Journal of Cardiology|May 21, 2011
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in left main patients with intermediate Global RiskDavide Capodanno, Piera Capranzano, Corrado Tamburino
European Heart Journal|January 19, 2024
Aspirin-free antiplatelet strategies after percutaneous coronary interventionsPiera Capranzano, David Moliterno, Davide Capodanno
Reviews on Recent Clinical Trials|March 5, 2010
Clinical development of selective anticoagulants: a state of the artPiera Capranzano, Davide Capodanno, Corrado Tamburino
International Journal of Cardiology|April 5, 2014
CABG versus PCI in diabetic patients with multivessel disease after risk stratification by the SYNTAX score: a pooled analysis of the SYNTAX and FREEDOM trialsDavide Capodanno, Piera Capranzano, Corrado Tamburino
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Discontinuation of anticoagulation therapy after atrial fibrillation ablation: the ALONE-AF and OCEAN studiesMario Campisi, Florinda Bonanno, Piera Capranzano
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 18, 2025
Should MitraClip also be used in less severe functional mitral regurgitation? The RESHAPE-HF2 studyPiera Capranzano, Bianca Pellizzeri, Luca Lombardo
Interventional Cardiology Clinics|August 26, 2019
Pharmacodynamics During Transition Between Platelet P2Y<sub>12</sub> Inhibiting TherapiesPiera Capranzano, Bruno Francaviglia, Dominick J Angiolillo
Pageof 23